A new study from UC San Francisco has uncovered a surprising mechanism by which the crucial signaling protein TGF-Beta can activate cellular receptors while still bound to its regulatory partner. Using advanced cryogenic electron microscopy (cryo-EM) techniques, researchers have shown that TGF-Beta can partially extend from its "straitjacket" protein, known as latency-associated protein (LAP), to interact with nearby receptors. 

This finding challenges the long-held belief that TGF-Beta must be fully released from LAP to function. The study, published in Cell, demonstrates that TGF-Beta's flexibility within LAP allows it to perform its signaling role even while tethered to the cell membrane.

The research team, led by Yifan Cheng and Stephen Nishimura, employed innovative cryo-EM approaches to capture the dynamic interactions between TGF-Beta, LAP, and cellular receptors. By systematically stabilizing different parts of the protein complex and analyzing the resulting data, they were able to visualize the subtle movements that enable TGF-Beta signaling.

"In cryo-EM, people tend to report on what they can see most clearly, but in our data, we realized there could be meaning in the fuzziest parts of the picture," said Nishimura.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

This discovery has significant implications for understanding cellular communication and may impact the development of therapies targeting TGF-Beta, including cancer treatments. The study suggests that the flexibility of signaling molecules may play a more important role in their function than previously recognized.

Cheng emphasized the broader implications of their findings: "From cell communication to cell surface molecules, to TGF-Beta, and then to disease modeling and structural biology, we hope these results can trigger people to think differently."